Health ASCO 2023: IDH mutation and improved cognitive functions in brain tumor patients by Alexandra Hartman Editor-in-Chief June 4, 2023 written by Alexandra Hartman Editor-in-Chief June 4, 2023 48 2023-06-04 12:19:42 – ASCO 2023 ASCO 2023 Patients with this tumor with the IDH 1 and 2 mutation improve their motor and cognitive functions, in addition to avoiding long-term relapses. Grade 2 gliomas with a mutation in the IDH gene are malignant brain tumors that cause considerable morbidity and premature death. 1685882522 #Vorasidenib #stops #grade #glioma #surgery #delays #chemo #radium Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X 0 comments 0 FacebookTwitterPinterestEmail Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity. previous post Despite Dementia, Bruce Willis Enjoys a Day at Disneyland with Wife and Children next post Amazon is negotiating with US carriers to provide low-cost mobile phone service You may also like Robotic-Assisted Joint Replacement Now Available at OhioHealth O’Bleness... February 18, 2026 Baduanjin: Ancient Chinese Practice Lowers Blood Pressure as... February 18, 2026 Even a Little Exercise Significantly Lowers Stroke Risk... February 18, 2026 Fish and Salamanders Reveal Ancient Secrets of Regeneration February 18, 2026 Trump AI Regulation Clash: States Push Back on... February 18, 2026 Alzheimer’s, Social Media & Health News: Feb 18... February 18, 2026 Aortic Stenosis: 200 Genes Offer Hope for New... February 18, 2026 Yuka-Approved Snacks: The 100/100 Rated Chips at Intermarché February 18, 2026 Disclosure of Competing Interests February 18, 2026 Vietnamese Math Prodigy: From IMO Gold to Top... February 18, 2026 Leave a Comment Cancel Reply Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
